Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

Dec 03, 2019 11:01 pm ET
Khiron Welcomes Legalization of Medical Cannabis in Brazil
Brazil represents the largest addressable market in Latin America with a population of 208 million and a potential USD $229 Million patient network for medical cannabis (New Frontier Data) Brazilian national health authority (ANVISA) approves the sale of medical cannabis products for sale by prescription and through pharmacies Khiron to participate in Brazil medical cannabis market through the Mercosur Regional Trading Bloc Regulations come into force 90 days after imminent posting on Federal Official Gazette TORONTO, Dec. 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Compan
Nov 29, 2019 04:00 pm ET
Khiron Announces Chairman Transition and Appointment of Audit Committee Chair
TORONTO, Nov. 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that Sidney Himmel has resigned as Director and Chair of the Board to pursue other interests, effective immediately.
Nov 27, 2019 04:30 pm ET
Khiron Announces Option and Restricted Share Unit Grants
TORONTO, Nov. 27, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America announced that it has granted stock options and restricted share units (RSUs) to certain directors and officers of the Company and its subsidiaries under the Company's Amended and Restated Stock Option Plan and Amended and Restated RSU Plan. 
Nov 26, 2019 06:00 am ET
Khiron Reports Q3 Fiscal 2019 Financial Results, With $47.9 Million Cash Balance and $2.8 Million in Quarterly Revenue
Ended the quarter with $47.9 million in cash and short-term investments Robust balance sheet puts Company in a position of strength ILANS clinics showed progressively stronger margins and an over 20% increase in revenues in Q3 Multi-country strategy advances with TSX-V approval for distribution and sale of Kuida CBD products in the United States, with sales launched in the US market in November, and;   Approval to sell Aceso hemp CBD brand in Colombia, targeted for entry in Q1 2020 Fulfilled European Union cosmetic product regulatory requirements for seven Kuida products for distribution int
Nov 24, 2019 11:01 pm ET
Khiron Receives First Colombian Authorization to Commercialize High-THC Cannabis for Domestic and Export Sales
Authorization for domestic and export purposes comes as a result of commercial quotas allocated to Khiron by the Colombian Technical Quotas Group ("TQG") for 2019 Permits Company to cultivate and commercialize psychoactive cannabis Includes authorization to export of whole plant extract to Uruguay and Brazil Positions Khiron to as the first LP to manufacture high-THC whole plant extract and produce customized medical cannabis prescriptions for domestic use TORONTO, Nov. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC)
Nov 20, 2019 11:01 pm ET
Khiron Director and 55th President of Mexico, Vicente Fox to Present Keynote at UK Cannabis Investor Conference
TORONTO, Nov. 21, 2019 /CNW/ -  Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that Company Director and 55th President of Mexico, Vicente Fox, will present a keynote address at the Bryan, Garnier & Co Cannabis Conference, taking place on Thursday, November 28, 2019 in London, UK.
Nov 18, 2019 11:01 pm ET
Khiron to be Exclusive Latin American Provider to Project Twenty21, Europe's Largest Medical Cannabis Study with 20,000 Patients
Khiron Life Sciences establishes early mover position to build its brand and product offering in the United Kingdom's nascent medical cannabis market Project Twenty21 will study medical cannabis's therapeutic effects on 20,000 patients - and build largest ever evidence base for UK National Health Service (NHS) provision of these medicines Real-world data registry will document patient outcomes in those prescribed medical cannabis and support health authority applications Project welcomed by The Royal College of Psychiatrists, peers, The British Pain Society, United Patients Alliance and lead
Nov 17, 2019 11:01 pm ET
Khiron Launches Kuida Brand in the US, Begins First Sales
First retail sales in US commence in beauty capital of Los Angeles on November 20, targeting US skincare market Initial distribution to include partnership with leading lifestyle media and retail brand Cannabis Now Activation at Cannabis Now's high-traffic Los Angeles location to target affluent, trendy audience of beauty and cannabis consumers Company to support sales through comprehensive marketing and branding campaign, including content to reach Cannabis Now's 4.2M audience Launch to kick off with experiential event on Nov. 20 at Cannabis Now flagship store US skincare market estimated a
Nov 10, 2019 11:01 pm ET
Khiron Receives Approval to Sell Aceso™ Hemp CBD Brand in Colombia
First Hemp CBD brand to enter Latin American market under Dixie Brands joint venture Builds on proven Aceso brand acceptance across US consumer market Product line includes indication-specific (heat and cool), hemp-derived CBD balms Approval secured from INVIMA for commercialization in Colombia of initial Aceso products, Alfa Balm (heat) and Sigma Balm (cool) Introduction to Colombian market in Q4 2019 with expansion to Chile and Uruguay in 2020 Latin America herbal/traditional topical analgesic and topical analgesics/Anaesthetic market estimated at US$380 million (Source: Euromonitor 2018)
Nov 10, 2019 11:01 pm ET
Khiron Receives Approval to Sell Aceso™ Hemp CBD Brand in Colombia
First Hemp CBD brand to enter Latin American market under Dixie Brands joint venture Builds on proven Aceso brand acceptance across US consumer market Product line includes indication-specific (heat and cool), hemp-derived CBD balms Approval secured from INVIMA for commercialization in Colombia of initial Aceso products, Alfa Balm (heat) and Sigma Balm (cool) Introduction to Colombian market in Q4 2019 with expansion to Chile and Uruguay in 2020 Latin America herbal/traditional topical analgesic and topical analgesics/Anaesthetic market estimated at US$380 million (Source: Euromonitor 2018) ...
Nov 05, 2019 11:01 pm ET
Khiron Enters First Latin American Cannabis Lines of Research Targeting U.S. $44 Billion Dermatological Drug Market
Clinical research partnership with Centro Dermatológico Federico Lleras Acosta (CDFLLA), focuses on effectiveness of medical cannabis for dermatological conditions defined in three main lines of research: Melanoma, Keratinocytes and Mycobacterial growth. Lines of research presented November 2, 2019 at II TeraCILAD dermatological conference with more than 1,000 LATAM dermatologists in attendance. Research initiated by Khiron and CDFLLA anticipated to begin in Q1 2020, representing first of its kind in Latin America Global dermatological (prescription) drug market valued at $38.4bn in 2017, ri
Nov 05, 2019 11:01 pm ET
Khiron Enters First Latin American Cannabis Lines of Research Targeting U.S. $44 Billion Dermatological Drug Market
Clinical research partnership with Centro Dermatológico Federico Lleras Acosta (CDFLLA), focuses on effectiveness of medical cannabis for dermatological conditions defined in three main lines of research: Melanoma, Keratinocytes and Mycobacterial growth. Lines of research presented November 2, 2019 at II TeraCILAD dermatological conference with more than 1,000 LATAM dermatologists in attendance. Research initiated by Khiron and CDFLLA anticipated to begin in Q1 2020, representing first of its kind in Latin America Global dermatological (prescription) drug market valued at $38.4bn in 2017, ri...
Nov 03, 2019 11:01 pm ET
Khiron Appoints Veteran Independent Director Deborah Rosati FCPA, FCA, ICD.D
TORONTO, Nov. 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that Mark Monaghan has resigned as a director of the Company and that Deborah Rosati FCPA, FCA, ICD.D has been appointed effective immediately to the Board of Directors of the Company. Ms. Rosati has over 30 years of experience in leading and managing high growth companies and joins the Board, effective immediately.
Nov 03, 2019 11:01 pm ET
Khiron Appoints Veteran Independent Director Deborah Rosati FCPA, FCA, ICD.D
TORONTO, Nov. 4, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that Mark Monaghan has resigned as a director of the Company and that Deborah Rosati FCPA, FCA, ICD.D has been appointed effective immediately to the Board of Directors of the Company. Ms. Rosati has over 30 years of experience in leading and managing high growth companies and joins the Board, effective immediately....
Nov 01, 2019 12:01 am ET
Khiron To Participate in Cowen 2nd Annual Boston Cannabis Conference
Company will present to institutional investors and join panel discussions covering developments in the cannabis industry
Nov 01, 2019 12:01 am ET
Khiron To Participate in Cowen 2nd Annual Boston Cannabis Conference
Company will present to institutional investors and join panel discussions covering developments in the cannabis industry...
Oct 31, 2019 12:01 am ET
Khiron to Host Live Investor Webcast on November 5, 2019
Khiron invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentation
Oct 31, 2019 12:01 am ET
Khiron to Host Live Investor Webcast on November 5, 2019
Khiron invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentation...
Oct 25, 2019 12:01 am ET
Kuida is One Year Old! First Export to the US market, UK Product Approval, and 300+ Points of Sale in Colombia
First import of Kuida products into the US now completed, with launch and sales to start in November 2019 E.U. cosmetic product regulatory requirements fulfilled for seven Kuida products, with commercialization in U.K. set for Q1 2020 New distribution agreements secured in Colombia, bringing total points-of-sale to 300+ Multi-channel distribution strategy rapidly advances to target US$135 billion global skincare market TORONTO, Oct. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis lea
Oct 25, 2019 12:01 am ET
Kuida is One Year Old! First Export to the US market, UK Product Approval, and 300+ Points of Sale in Colombia
First import of Kuida products into the US now completed, with launch and sales to start in November 2019 E.U. cosmetic product regulatory requirements fulfilled for seven Kuida products, with commercialization in U.K. set for Q1 2020 New distribution agreements secured in Colombia, bringing total points-of-sale to 300+ Multi-channel distribution strategy rapidly advances to target US$135 billion global skincare market TORONTO, Oct. 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated canna...
Oct 16, 2019 12:30 am ET
Khiron Participates in Mexican Senate Cannabis Regulation Forum
Mexico poised to become the largest market in the world to fully legalize cannabis nationwideForum with industry leaders to guide legislation to legalize both adult-use and medical cannabis in Mexico – currently expected by the end of October 2019Builds on Khiron's history of leadership and advocacy in Mexico's developing cannabis industry Company holds close relationships with key stakeholders in Mexico, including former president of Mexico and current Khiron board member Vicente Fox, as well as medical associations across the country Company positioned to play a leading role in the Mexican
Oct 16, 2019 12:30 am ET
Khiron Participates in Mexican Senate Cannabis Regulation Forum
Mexico poised to become the largest market in the world to fully legalize cannabis nationwideForum with industry leaders to guide legislation to legalize both adult-use and medical cannabis in Mexico – currently expected by the end of October 2019Builds on Khiron's history of leadership and advocacy in Mexico's developing cannabis industry Company holds close relationships with key stakeholders in Mexico, including former president of Mexico and current Khiron board member Vicente Fox, as well as medical associations across the country Company positioned to play a leading role in the Mexican...
Oct 15, 2019 12:01 am ET
Khiron to Commercialize Kuida® Brand in U.K.
Kuida is the first CBD skincare portfolio of products launched in Colombia from a federally approved cannabis company Company has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida® products Initial UK import anticipated for Q4 2019 Company has received a "no objection" letter from TSXV for distribution of the Kuida products in the UK UK skincare market estimated at US$3.8 billion in 2018 (Source: Euromonitor) TORONTO, Oct. 15, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated c
Oct 15, 2019 12:01 am ET
Khiron to Commercialize Kuida® Brand in U.K.
Kuida is the first CBD skincare portfolio of products launched in Colombia from a federally approved cannabis company Company has fulfilled E.U. cosmetic product regulatory requirements for seven Kuida® products Initial UK import anticipated for Q4 2019 Company has received a "no objection" letter from TSXV for distribution of the Kuida products in the UK UK skincare market estimated at US$3.8 billion in 2018 (Source: Euromonitor) TORONTO, Oct. 15, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integ...
Oct 08, 2019 12:01 am ET
Khiron to Participate at BMO & TMX Hemp & Medical Cannabis Conference in London, UK
TORONTO, Oct. 8, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference, taking place in in London, UK on October 16, 2019.
Oct 08, 2019 12:01 am ET
Khiron to Participate at BMO & TMX Hemp & Medical Cannabis Conference in London, UK
TORONTO, Oct. 8, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce its participation at the BMO & TMX Hemp & Medical Cannabis Conference, taking place in in London, UK on October 16, 2019....
Sep 26, 2019 12:01 am ET
Khiron to Present and Host Attendees at First MJBizDaily Latin American Cannabis Symposium
Symposium brings together industry leaders, investors and policy decision-makers for two-day event spotlighting the potential of the Latin American cannabis industry CEO and Director Alvaro Torres and Skin Unit Director Elsa Navarro to participate in panels covering cannabis investing & finance and CBD cosmetics topics Latin America positioned to be a vital player in global cannabis industry, valued at an estimated US$12 Billion within the next decade (Source Prohibition Partners) TORONTO, Sept. 26, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB
Sep 26, 2019 12:01 am ET
Khiron to Present and Host Attendees at First MJBizDaily Latin American Cannabis Symposium
Symposium brings together industry leaders, investors and policy decision-makers for two-day event spotlighting the potential of the Latin American cannabis industry CEO and Director Alvaro Torres and Skin Unit Director Elsa Navarro to participate in panels covering cannabis investing & finance and CBD cosmetics topics Latin America positioned to be a vital player in global cannabis industry, valued at an estimated US$12 Billion within the next decade (Source Prohibition Partners) TORONTO, Sept. 26, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN),...
Sep 25, 2019 12:01 am ET
Khiron Secures Approval to Sell Three More CBD Wellness Products
Approval to sell three additional Kuida® CBD products focused on anti-aging, hydration and everyday skin care Expands revenue generating Kuida® cosmeceutical portfolio to 10 SKU´s First sales expected in Q4 for the newly approved products Kuida® portfolio first INVIMA-approved branded CBD beauty product in Colombia TORONTO, Sept. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company has received approval from IN
Sep 25, 2019 12:01 am ET
Khiron Secures Approval to Sell Three More CBD Wellness Products
Approval to sell three additional Kuida® CBD products focused on anti-aging, hydration and everyday skin care Expands revenue generating Kuida® cosmeceutical portfolio to 10 SKU´s First sales expected in Q4 for the newly approved products Kuida® portfolio first INVIMA-approved branded CBD beauty product in Colombia TORONTO, Sept. 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company has received approval ...
Sep 11, 2019 08:35 am ET
/R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Sep 10, 2019 08:30 am ET
Khiron To Webcast Live At VirtualInvestorConferences.com On September 12th
TORONTO, Sept. 10, 2019 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that Khiron CEO, Alvaro Torres will present life at VirtualInvestorConferences.com on September 12th....
Sep 06, 2019 09:15 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th
NEW YORK, Sept. 6, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET, with the first live webcast at 9:30 AM ET, on Thursday, September 12th....
Sep 04, 2019 12:01 am ET
Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity
Facility in Juan Lacaze includes GAP-compliant 8,000 m2 (86,111 sq.ft) cultivation area and a GMP-compliant 1,800 m2 (19,375 sq.ft) processing plant, with a production capacity of 17 tons per year Increases Khiron's total production capacity and strengthens ability to export and supply cannabis across the Mercosur trading bloc, with access to Brazil and Europe Medical cannabis markets in Brazil and Europe are expected to be respectively worth $144.3 billion USD and €115.7 Billion by 2028 (Source: Prohibition Partners) Construction scheduled for completion in mid Q3 2020 TORONTO, Sept. 4, 20
Sep 04, 2019 12:01 am ET
Khiron Initiates Construction of Cultivation and Processing Facility in Uruguay, Expanding Multi-Jurisdiction and Export Capacity
Facility in Juan Lacaze includes GAP-compliant 8,000 m2 (86,111 sq.ft) cultivation area and a GMP-compliant 1,800 m2 (19,375 sq.ft) processing plant, with a production capacity of 17 tons per year Increases Khiron's total production capacity and strengthens ability to export and supply cannabis across the Mercosur trading bloc, with access to Brazil and Europe Medical cannabis markets in Brazil and Europe are expected to be respectively worth $144.3 billion USD and €115.7 Billion by 2028 (Source: Prohibition Partners) Construction scheduled for completion in mid Q3 2020 TORONTO, Sept. 4, 20...
Aug 29, 2019 12:01 am ET
Khiron Secures Exclusive Endorsement from The Colombian Association of Gerontology and Geriatrics
Seniors identified among the fastest growing adopters of medical cannabis (Source: University of Colorado) Over 1 million patients in Colombia are elderly and suffer from chronic pain, anxiety, depression or are in palliative care (Source: IMS quintiles) Khiron medical product pipeline focused on priority conditions associated with aging, including chronic pain management Khiron neurologist Paula Martinez to present keynote to more than 1,500 health professionals at Association congress in Cali, Colombia Endorsement will advance Company strategy to meet the priority needs of over 68 million
Aug 29, 2019 12:01 am ET
Khiron Secures Exclusive Endorsement from The Colombian Association of Gerontology and Geriatrics
Seniors identified among the fastest growing adopters of medical cannabis (Source: University of Colorado) Over 1 million patients in Colombia are elderly and suffer from chronic pain, anxiety, depression or are in palliative care (Source: IMS quintiles) Khiron medical product pipeline focused on priority conditions associated with aging, including chronic pain management Khiron neurologist Paula Martinez to present keynote to more than 1,500 health professionals at Association congress in Cali, Colombia Endorsement will advance Company strategy to meet the priority needs of over 68 million ...
Aug 26, 2019 07:00 am ET
Khiron Life Sciences Reports Second Quarter Fiscal 2019 Financial Results
Advances multi-country operator strategy with acquisition of NettaGrowth, securing first medical THC and CBD cannabis license and cultivation capacity in Uruguay, and potential for access to Brazilian market Closes $28,751,035 bought deal financing, including full exercise of over-allotment option Completed the quarter with $55.8 million in cash Expands distribution for Kuida cosmeceutical brand, signing distribution agreements with Fedco, Linio, Cafam – large consumer distribution channels in Colombia. Subsequent to the quarter signed distribution agreement with Grupo Exito, one of South Am
Aug 26, 2019 07:00 am ET
Khiron Life Sciences Reports Second Quarter Fiscal 2019 Financial Results
Advances multi-country operator strategy with acquisition of NettaGrowth, securing first medical THC and CBD cannabis license and cultivation capacity in Uruguay, and potential for access to Brazilian market Closes $28,751,035 bought deal financing, including full exercise of over-allotment option Completed the quarter with $55.8 million in cash Expands distribution for Kuida cosmeceutical brand, signing distribution agreements with Fedco, Linio, Cafam – large consumer distribution channels in Colombia. Subsequent to the quarter signed distribution agreement with Grupo Exito, one of South Am...
Aug 22, 2019 12:01 am ET
Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ("UHPLC" & "HPLC") technology, gas chromatography, stability testing, microbiology and heavy metals testingPhysical chemical cannabis testing lab has a capacity of up to 70 daily UHPLC & HPLC cannabinoid samples, 15 daily gas chromatography samples, and 2,000 monthly heavy metals samples. Microbiological testing lab has a capacity of up to 20 daily samples State-of-the-art testing la
Aug 22, 2019 12:01 am ET
Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ("UHPLC" & "HPLC") technology, gas chromatography, stability testing, microbiology and heavy metals testingPhysical chemical cannabis testing lab has a capacity of up to 70 daily UHPLC & HPLC cannabinoid samples, 15 daily gas chromatography samples, and 2,000 monthly heavy metals samples. Microbiological testing lab has a capacity of up to 20 daily samples State-of-the-art testing la...
Aug 20, 2019 12:01 am ET
Khiron Announces DTC Eligibility, Increasing Access for U.S. Investors
TORONTO, Aug. 20, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.
Aug 20, 2019 12:01 am ET
Khiron Announces DTC Eligibility, Increasing Access for U.S. Investors
TORONTO, Aug. 20, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States....
Aug 14, 2019 09:00 pm ET
Khiron Provides Clarification of August 12, 2019 News Release
TORONTO, Aug. 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019.
Aug 14, 2019 09:00 pm ET
Khiron Provides Clarification of August 12, 2019 News Release
TORONTO, Aug. 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. ...
Aug 12, 2019 12:01 am ET
Khiron Boosts European Expansion With Key Executive Appointments
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal Officer for Khiron Europe Both executives join Khiron from one of the world's largest cannabis companies Region's medical cannabis industry estimated to be worth €115.7 Billion by 2028 (Prohibition Partners) TORONTO, Aug. 12, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core opera
Aug 12, 2019 12:01 am ET
Khiron Boosts European Expansion With Key Executive Appointments
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal Officer for Khiron Europe Both executives join Khiron from one of the world's largest cannabis companies Region's medical cannabis industry estimated to be worth €115.7 Billion by 2028 (Prohibition Partners) TORONTO, Aug. 12, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with cor...
Aug 08, 2019 12:01 am ET
Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider
Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate of Suramericana S.A., one of Latin America's largest insurance companies with a presence in nine countries including Mexico, Chile and Uruguay Pilot program between EPS SURA and ILANS will leverage both parties' resources to enhance patient access to integrated healthcare management models Pilot program forms basis of model to generate predictable and recurring revenue for the Company Furt
Aug 08, 2019 12:01 am ET
Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider
Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate of Suramericana S.A., one of Latin America's largest insurance companies with a presence in nine countries including Mexico, Chile and Uruguay Pilot program between EPS SURA and ILANS will leverage both parties' resources to enhance patient access to integrated healthcare management models Pilot program forms basis of model to generate predictable and recurring revenue for the Company Furt...
Aug 07, 2019 12:01 am ET
Khiron Signs Kuida Distribution Agreement with Grupo Éxito, South America's Market Leading Retail Group
Distribution agreement with Grupo Éxito includes initial Kuida presence in 5 key market Éxito WOW concept stores and 16 Éxito traditional format stores with a potential expansion planned across Colombia.  Grupo Éxito has a multinational retail presence in Colombia, Brazil, Argentina and Uruguay and operates 1,533 stores. Kuida to be introduced as key addition to the retailer's cosmetics products category, with experience centres and consultants in each Éxito WOW store to support sales and brand awareness. Accelerates Company's multi-channel brand distribution strategy targeting U.S. $7.9 bil
Aug 07, 2019 12:01 am ET
Khiron Signs Kuida Distribution Agreement with Grupo Éxito, South America's Market Leading Retail Group
Distribution agreement with Grupo Éxito includes initial Kuida presence in 5 key market Éxito WOW concept stores and 16 Éxito traditional format stores with a potential expansion planned across Colombia.  Grupo Éxito has a multinational retail presence in Colombia, Brazil, Argentina and Uruguay and operates 1,533 stores. Kuida to be introduced as key addition to the retailer's cosmetics products category, with experience centres and consultants in each Éxito WOW store to support sales and brand awareness. Accelerates Company's multi-channel brand distribution strategy targeting U.S. $7.9 bil...
Aug 06, 2019 12:01 am ET
Khiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
Khiron receives conditional TSXV approval for Latin American joint venture with Dixie Brands and U.S. distribution and sale of Kuida cosmeceutical line Conditional approval subject only to receipt of customary closing documentation Accelerates strategy as first mover CBD brand targeting U.S. $20 Billion United States skincare market (Source: Euromonitor) Commercialization of Kuida products in the U.S. market anticipated in early 2020 Latin American commercialization of Dixie CBD-infused products beginning in 2020 TORONTO and DENVER, Aug. 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron")
Aug 06, 2019 12:01 am ET
Khiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
Khiron receives conditional TSXV approval for Latin American joint venture with Dixie Brands and U.S. distribution and sale of Kuida cosmeceutical line Conditional approval subject only to receipt of customary closing documentation Accelerates strategy as first mover CBD brand targeting U.S. $20 Billion United States skincare market (Source: Euromonitor) Commercialization of Kuida products in the U.S. market anticipated in early 2020 Latin American commercialization of Dixie CBD-infused products beginning in 2020 TORONTO and DENVER, Aug. 6, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("K...
Aug 06, 2019 12:01 am ET
Khiron and Dixie Receive Conditional TSXV Approval for Roll-Out of Kuida Cosmeceutical Line in U.S. Market and Cannabis-Infused Products in Latin America
Khiron receives conditional TSXV approval for Latin American joint venture with Dixie Brands and U.S. distribution and sale of Kuida cosmeceutical line Conditional approval subject only to receipt of customary closing documentation Accelerates strategy as first mover CBD brand targeting U.S. $20 Billion United States skincare market (Source: Euromonitor) Commercialization of Kuida products in the U.S. market anticipated in early 2020 Latin American commercialization of Dixie CBD-infused products beginning in 2020 TORONTO and DENVER, Aug. 6, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("K...
Aug 01, 2019 04:30 pm ET
Khiron Provides Update on Canapalife Group Transaction
TORONTO, Aug. 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, today provided an update on the Company's previously announced non-binding LOI with Canapalife Group. The Company confirms the expiry of the LOI and that the parties have mutually agreed not to proceed with the proposed transaction.
Aug 01, 2019 04:30 pm ET
Khiron Provides Update on Canapalife Group Transaction
TORONTO, Aug. 1, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, today provided an update on the Company's previously announced non-binding LOI with Canapalife Group. The Company confirms the expiry of the LOI and that the parties have mutually agreed not to proceed with the proposed transaction. ...
Aug 01, 2019 12:01 am ET
Khiron Begins Pre-clinical Medical Cannabis Studies with Leading Academic Institutes in Uruguay
Patient-focused studies advance progress towards global clinical trials on Khiron strains to treat inflammation, oxidative and nervous system disorders Co-sponsored with Uruguay government using Company strains, 18-month studies represent one of the most significant private-public medical cannabis initiatives in Latin America Project awarded matching financing support by Uruguay government for its medical innovation Uruguay market provides direct strategic opportunity of 3 million patients for medical cannabis with potential entry to Brazil, Argentina and Paraguay under Mercosur trade bloc
Aug 01, 2019 12:01 am ET
Khiron Begins Pre-clinical Medical Cannabis Studies with Leading Academic Institutes in Uruguay
Patient-focused studies advance progress towards global clinical trials on Khiron strains to treat inflammation, oxidative and nervous system disorders Co-sponsored with Uruguay government using Company strains, 18-month studies represent one of the most significant private-public medical cannabis initiatives in Latin America Project awarded matching financing support by Uruguay government for its medical innovation Uruguay market provides direct strategic opportunity of 3 million patients for medical cannabis with potential entry to Brazil, Argentina and Paraguay under Mercosur trade bloc ...
Jul 30, 2019 05:55 pm ET
Khiron Announces Final Approval of Acquisition of NettaGrowth
TORONTO, July 30, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company has received final approval from the TSX Venture Exchange ("TSXV") to close its previously announced acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which owns all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"). As consideration for the Acquisition, Khiron issued 8,498,821 common shares to the shareholders o
Jul 30, 2019 05:55 pm ET
Khiron Announces Final Approval of Acquisition of NettaGrowth
TORONTO, July 30, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company has received final approval from the TSX Venture Exchange ("TSXV") to close its previously announced acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which owns all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"). As consideration for the Acquisition, Khiron issued 8,498,821 common shares to the shareho...
Jul 25, 2019 12:01 am ET
Khiron Life Sciences Added to NYSE-Listed The Cannabis ETF
TORONTO, July 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has been added to The Cannabis ETF (NYSE: THCX) ("THCX"), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index, which is a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries.
Jul 25, 2019 12:01 am ET
Khiron Life Sciences Added to NYSE-Listed The Cannabis ETF
TORONTO, July 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has been added to The Cannabis ETF (NYSE: THCX) ("THCX"), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index, which is a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries. ...
Jul 17, 2019 12:01 am ET
Khiron Obtains Final Approval to Commercialize CBD Production and Receives Approval for an additional 17 Cannabis Strains from Colombian Agricultural Institute
Khiron has now secured all approvals required to commercialize current CBD cultivation and production for medical purposes. Commercial sales expected for third quarter of 2019 Initial harvest expected to produce CBD extract in 2019 to supply Khiron´s established medical cannabis distribution channel of over 1.0 million potential patients Khiron has now registered a total of 22 strains with Colombian Agricultural Institute ("ICA"). Production includes full profile of CBD and THC strains specifically selected for key target indications Khiron will now seek commercial quota for the commercializ
Jul 17, 2019 12:01 am ET
Khiron Obtains Final Approval to Commercialize CBD Production and Receives Approval for an additional 17 Cannabis Strains from Colombian Agricultural Institute
Khiron has now secured all approvals required to commercialize current CBD cultivation and production for medical purposes. Commercial sales expected for third quarter of 2019 Initial harvest expected to produce CBD extract in 2019 to supply Khiron´s established medical cannabis distribution channel of over 1.0 million potential patients Khiron has now registered a total of 22 strains with Colombian Agricultural Institute ("ICA"). Production includes full profile of CBD and THC strains specifically selected for key target indications Khiron will now seek commercial quota for the commercializ...
Jul 16, 2019 12:01 am ET
Khiron Targets Over 40,000 Beauty Industry Leaders with Kuida Skin Care Brand at Cosmoprof North America
Full portfolio of Kuida products will be exhibited at the event's Discover Beauty Pavilion to over 40,000 retail buyers, distributors, and beauty industry professionals Kuida is the first Colombian mass-market CBD cosmeceutical brand to showcase at Cosmoprof Participation in Cosmoprof North America marks crucial step towards expansion of Kuida into the United States, subject to TSX approval, targeting $20 billion dollar U.S. cosmetic market (Euromonitor) Further solidifies strong relationship between Kuida and a growing network of retailers, distributors and buyers, as the brand continues to
Jul 16, 2019 12:01 am ET
Khiron Targets Over 40,000 Beauty Industry Leaders with Kuida Skin Care Brand at Cosmoprof North America
Full portfolio of Kuida products will be exhibited at the event's Discover Beauty Pavilion to over 40,000 retail buyers, distributors, and beauty industry professionals Kuida is the first Colombian mass-market CBD cosmeceutical brand to showcase at Cosmoprof Participation in Cosmoprof North America marks crucial step towards expansion of Kuida into the United States, subject to TSX approval, targeting $20 billion dollar U.S. cosmetic market (Euromonitor) Further solidifies strong relationship between Kuida and a growing network of retailers, distributors and buyers, as the brand continues to...
Jul 15, 2019 12:01 am ET
Khiron Provides Corporate Update on Commercial and Operational Activities
Colombia commercial production anticipated to be commercialized in Q3. All cultivation, extraction and testing facilities operating and in optimal condition Potential addressable patient network of over 1 million individuals, represented by over 5,000 doctors through six medical association endorsements Core medical cannabis distribution channels secured with arrangement for over 900 retail locations Wellness line secured distribution agreements with largest retails of product category throughout Colombia, across 176 points of sale. Commenced jurisdictional and product portfolio expansion Cu
Jul 15, 2019 12:01 am ET
Khiron Provides Corporate Update on Commercial and Operational Activities
Colombia commercial production anticipated to be commercialized in Q3. All cultivation, extraction and testing facilities operating and in optimal condition Potential addressable patient network of over 1 million individuals, represented by over 5,000 doctors through six medical association endorsements Core medical cannabis distribution channels secured with arrangement for over 900 retail locations Wellness line secured distribution agreements with largest retails of product category throughout Colombia, across 176 points of sale. Commenced jurisdictional and product portfolio expansion Cu...
Jul 09, 2019 12:30 am ET
Khiron CEO Alvaro Torres to Present at 2019 Canaccord Genuity U.S. Annual Growth Conference
Company Invited to Particpate in Strategic US Investor Conference
Jul 09, 2019 12:30 am ET
Khiron CEO Alvaro Torres to Present at 2019 Canaccord Genuity U.S. Annual Growth Conference
Company Invited to Particpate in Strategic US Investor Conference...
Jul 08, 2019 12:30 am ET
Khiron Leads Cannabis Education at XLIV International Course of Internal Medicine, Reaching Over 2,000 Medical Specialists in Mexico
Khiron was the sole cannabis company to present during the four-day symposium organized by the Mexican College of Internal Medicine Event participation builds upon Khiron's relationship with the Mexican College of Internal Medicine, a leading association of internal medicine specialists that previously endorsed the company in 2018 Conference attendees included over 2000 leading specialists, physicians and healthcare professionals from across Mexico TORONTO, July 8, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core oper
Jul 08, 2019 12:30 am ET
Khiron Leads Cannabis Education at XLIV International Course of Internal Medicine, Reaching Over 2,000 Medical Specialists in Mexico
Khiron was the sole cannabis company to present during the four-day symposium organized by the Mexican College of Internal Medicine Event participation builds upon Khiron's relationship with the Mexican College of Internal Medicine, a leading association of internal medicine specialists that previously endorsed the company in 2018 Conference attendees included over 2000 leading specialists, physicians and healthcare professionals from across Mexico TORONTO, July 8, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with co...
Jul 03, 2019 08:35 am ET
Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
Jul 03, 2019 08:35 am ET
Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing
NEW YORK, July 3, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Grit Capital, today announced that the presentations from our recent virtual event are now available for on-demand viewing. Eight public & private company executives provided insight on innovation, consolidation, international expansion and specialization in millennial investment industries. Login to now to watch the presentations and hear answers to questions from the audience....
Jul 01, 2019 12:30 am ET
Khiron Welcomes EU Trade Deal with Latin American Countries
TORONTO, July 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, applauds the EU-Mercosur Trade Agreement announced between the European Union and Mercosur, the Latin American trading block made up of Argentina, Brazil, Uruguay and Paraguay. Khiron is active among Mercosur jurisdictions with a recently completed acquisition of NettaGrowth International, a cannabis company based in Uruguay.
Jul 01, 2019 12:30 am ET
Khiron Welcomes EU Trade Deal with Latin American Countries
TORONTO, July 1, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, applauds the EU-Mercosur Trade Agreement announced between the European Union and Mercosur, the Latin American trading block made up of Argentina, Brazil, Uruguay and Paraguay. Khiron is active among Mercosur jurisdictions with a recently completed acquisition of NettaGrowth International, a cannabis company based in Uruguay....
Jun 25, 2019 12:05 am ET
Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference
TORONTO, June 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, announces today that Company president Chris Naprawa will be presenting at the Grit Capital Virtual Investor Conference to be hosted on June 26, 2019.
Jun 21, 2019 12:50 pm ET
Grit Capital's Live-Stream Virtual Investor Conference June 26th
9 Company Executives of small cap millennial themed companies share their vision and answer questions live at VirtualInvestorConferences.com
Jun 19, 2019 12:05 am ET
Khiron Completes Acquisition of NettaGrowth International Advancing Multi-Country Operator Strategy
The Acquisition of NettaGrowth International Inc. provides Khiron with up to an additional 120 tonnes of licenced production capacity Diversifies Khiron´s licence composition to include medical use and flower cultivation distribution capabilities Secures a scientific and investigation agreement with Institute Pasteur of Montevideo, a respected biotechnology researcher and developer in Uruguay Mr. Joseph Mimran, experienced brand builder and entrepreneur, joins the board of Khiron Colombia S.A.S TORONTO, June 19, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHR
Jun 14, 2019 06:56 am ET
Khiron Announces Changes to Leadership Team with Appointment of Wendy Kaufman as CFO
TORONTO, June 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, today announced the appointment of Wendy Kaufman as CFO, effective July 2, 2019. Ms. Kaufman, a Chartered Professional Accountant, brings over 20 years of international financial experience, having served most recently as CFO at Pasinex Resources Limited.  Ms. Kaufman has significant experience with Latin American operations, gained during her tenure as CFO at Primero Mining Corporation, and previous
Jun 07, 2019 12:01 am ET
Khiron Receives Regulatory Approval for Uruguay Acquisition
TORONTO, June 7, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned.
Jun 06, 2019 08:35 am ET
Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations
Jun 03, 2019 08:07 am ET
/R E P E A T -- Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year/
TORONTO, June 2, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce the completion of construction and the initiation of operations in its cultivation, extraction, and analysis facilities in Ibague, Colombia, where significant progress has been made towards the commercial registration and production of medical cannabis products targeting 6 million potential patients across the country.
Jun 02, 2019 05:58 pm ET
Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year
TORONTO, June 2, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce the completion of construction and the initiation of operations in its cultivation, extraction, and analysis facilities in Ibague, Colombia, where significant progress has been made towards the commercial registration and production of medical cannabis products targeting 6 million potential patients across the country.
May 31, 2019 08:35 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
May 30, 2019 09:20 pm ET
Khiron Life Sciences Reports First Quarter Fiscal 2019 Financial Results
Expands to second jurisdiction on closing of agreement with Dayacann to enter Chilean medical cannabis market
May 29, 2019 12:05 am ET
Khiron Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF
TORONTO, May 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America is pleased to announce today its addition to the MJ ETFMG Alternative Harvest ETF (NYSE:MJ) (the "Fund"), a fund with approximately US$1.22 billion in assets currently under management. This represents an important development for the Company as it advances its strategy as a Latin American cannabis company with global growth.
May 28, 2019 10:19 am ET
Khiron Announces Closing of $28.75 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
May 13, 2019 04:30 pm ET
Khiron Provides Update on Transaction to Acquire NettaGrowth
TORONTO, May 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned and the Company is in the latter stages of securing local regulatory approvals in Uruguay for the completion of th
May 10, 2019 06:54 pm ET
Khiron Mails and Files Circular Relating to its Annual General and Special Meeting of Shareholders
Annual General and Special Meeting of Shareholders scheduled for May 31, 2019 at 11 a.m. (Toronto time). Proxy voting deadline is May 29, 2019 at 11 a.m. (Toronto time). Board of Directors recommends that Shareholders vote FOR all resolutions. TORONTO, May 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, today announced it has commenced the mailing of the management information circular and other related materials (collectively, the "Meeting Materials"
May 06, 2019 05:12 pm ET
Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
May 01, 2019 08:00 am ET
Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update
Secured approximately $40 million of investment capital for cultivation site construction, product development and distribution Became the first Colombian cannabis company to list on the TSX Venture Exchange Geographic footprint to countries including Colombia, Mexico, Chile, Peru, Uruguay and Italy Received first INVIMA approvals for seven CBD-based cosmeceutical products in Colombia. Generated first revenue in Q4 2018 with the commercialization of the Kuida® brand of cosmeceutical products Increased potential cultivation capacity to 220 tonnes per annum through organic growth and pending a
Apr 30, 2019 12:05 am ET
Khiron Gets Kuida® Into Another 150 Stores
Distribution agreement with Cafam includes initial Kuida® product orders for 49 points of sale Further expansion to increase to 150 stores in first 6 months Cafam operates total of 270 stores across over 60 market in Colombia Accelerates Company's multi-channel brand distribution strategy targeting $10 Billion Latin American skincare market TORONTO, April 30, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has signed a distribut
Apr 30, 2019 12:05 am ET
Khiron Gets Kuida® Into Another 150 Stores
Distribution agreement with Cafam includes initial Kuida® product orders for 49 points of sale Further expansion to increase to 150 stores in first 6 months Cafam operates total of 270 stores across over 60 market in Colombia Accelerates Company's multi-channel brand distribution strategy targeting $10 Billion Latin American skincare market TORONTO, April 30, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has signed a di...
Apr 29, 2019 12:05 am ET
Khiron Life Sciences Signs Letter of Intent to Establish Medical Cannabis Distribution Agreement for Over 900 pharmacies in Colombia
LOI with Copservir Ltda, Colombia's largest pharmacy chain with over 900 pharmacies across 200 cities and municipalities across the country, and sales of over CAD 500 Million per year It is anticipated that the arrangement will ensure critical infrastructure for Khiron to distribute its made-to-order pharmaceutical compounds to more than 5 million potential patients (Source: Quintiles IMS) in Colombia Upon execution of a definitive agreement, Khiron expects to establish Colombia's most advanced distribution platform for medical cannabis products Provides ease of access at pharmacy stores and
Apr 29, 2019 12:05 am ET
Khiron Life Sciences Signs Letter of Intent to Establish Medical Cannabis Distribution Agreement for Over 900 pharmacies in Colombia
LOI with Copservir Ltda, Colombia's largest pharmacy chain with over 900 pharmacies across 200 cities and municipalities across the country, and sales of over CAD 500 Million per year It is anticipated that the arrangement will ensure critical infrastructure for Khiron to distribute its made-to-order pharmaceutical compounds to more than 5 million potential patients (Source: Quintiles IMS) in Colombia Upon execution of a definitive agreement, Khiron expects to establish Colombia's most advanced distribution platform for medical cannabis products Provides ease of access at pharmacy stores and...
Apr 25, 2019 11:40 am ET
Khiron Expands to Europe, Signs Non-Binding LOI to Acquire Italy-Based Canapalife Group
TORONTO, April 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with its core operations in Latin America, announced today that the Company has entered into a non-binding letter of agreement to acquire 100% of the outstanding securities of Canapalife S.r.l. and 100% of the economic interest in Campodoro S.r.l. ("Canapalife Group") from Alvaro Garro and Paolo Puggioni (the "Vendors"), being the sole shareholders of Canapalife Group.
Apr 25, 2019 11:40 am ET
Khiron Expands to Europe, Signs Non-Binding LOI to Acquire Italy-Based Canapalife Group
TORONTO, April 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with its core operations in Latin America, announced today that the Company has entered into a non-binding letter of agreement to acquire 100% of the outstanding securities of Canapalife S.r.l. and 100% of the economic interest in Campodoro S.r.l. ("Canapalife Group") from Alvaro Garro and Paolo Puggioni (the "Vendors"), being the sole shareholders of Canapalife Group....
Apr 17, 2019 12:05 am ET
Khiron Appointments Larry Holifield, Former U.S. DEA Regional Director, Mexico and Central America as Khiron Security and Compliance Director, Mexico,- Joins Chief Compliance Officer Matt Murphy to Ex
Appointment of Mr. Holifield enhances Khiron's Mexico security and compliance capabilities and operational network Mr. Holifield joins a growing team for Mexico that includes country manager, Luis Chaves, and Mr. Vicente Fox, former Mexican president and Khiron board member Company taking leadership position in Mexico as co-host of Cannamexico World Summit 2019, April 25-26, a medical, regulatory and industry cannabis conference with over 2,000 attendees from ten countries, making it the largest of its kind in the region Appointment expands on Company's stated multi-market growth strategy wi
Apr 17, 2019 12:05 am ET
Khiron Appointments Larry Holifield, Former U.S. DEA Regional Director, Mexico and Central America as Khiron Security and Compliance Director, Mexico,- Joins Chief Compliance Officer Matt Murphy to Ex
Appointment of Mr. Holifield enhances Khiron's Mexico security and compliance capabilities and operational network Mr. Holifield joins a growing team for Mexico that includes country manager, Luis Chaves, and Mr. Vicente Fox, former Mexican president and Khiron board member Company taking leadership position in Mexico as co-host of Cannamexico World Summit 2019, April 25-26, a medical, regulatory and industry cannabis conference with over 2,000 attendees from ten countries, making it the largest of its kind in the region Appointment expands on Company's stated multi-market growth strategy wi...
Apr 10, 2019 10:54 am ET
The Beauty of CBD: Cannabis Companies Shift Focus towards Beauty and Wellness  
Investorideas.com, a leading investor news resource covering cannabis stocks, releases a snapshot looking at the many cannabis companies looking into the CBD beauty and wellness sector and why this sector is gaining such momentum. According to one...
Apr 10, 2019 10:48 am ET
Khiron Announces Partnership to Initiate the First Cannabis Clinical Research in Latin America and Expand Product Development to Address the Global Skincare Market
Anticipated to materially advance efforts to meet consumer needs in the global $131 Billion USD skincare market (Source: Euromonitor International) First-ever cannabis clinical research study initiated in Latin America key to developing new dermo cosmetic and dermatological product lines for Khiron Skin Unit and strengthen Kuida® portfolio First mover advantage in development of dermo cosmetic products with cannabis worldwide Entered into multi-year agreement with Centro Dermatológico Federico Lleras Acosta (CDFLLA), leading Latin American institution, to jointly conduct medical cannabis res
Apr 10, 2019 10:48 am ET
Khiron Announces Partnership to Initiate the First Cannabis Clinical Research in Latin America and Expand Product Development to Address the Global Skincare Market
Anticipated to materially advance efforts to meet consumer needs in the global $131 Billion USD skincare market (Source: Euromonitor International) First-ever cannabis clinical research study initiated in Latin America key to developing new dermo cosmetic and dermatological product lines for Khiron Skin Unit and strengthen Kuida® portfolio First mover advantage in development of dermo cosmetic products with cannabis worldwide Entered into multi-year agreement with Centro Dermatológico Federico Lleras Acosta (CDFLLA), leading Latin American institution, to jointly conduct medical cannabis res...
Apr 09, 2019 10:03 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, April 9, 2019 /CNW/ - Trading resumes in:
Apr 09, 2019 09:50 am ET
Khiron Advances Multi-Country Operator Strategy by Signing Definitive Agreement to Acquire Licence in Uruguay
Upon completion of the Acquisition of NettaGrowth International Inc., Khiron´s total production capacity is expected to increase to up to 220 tonnes Diversifies Khiron´s licence composition to include adult use and flower cultivation distribution capabilities Secures a scientific and investigation agreement with Institute Pasteur of Montevideo, a respected biotechnology researcher and developer in Uruguay Concurrent with closing, Mr. Michael Beck, experienced capital markets professional and entrepreneur, to join the board of Khiron, and Mr. Joseph Mimran, experienced brand builder and entre
Apr 09, 2019 09:50 am ET
Khiron Advances Multi-Country Operator Strategy by Signing Definitive Agreement to Acquire Licence in Uruguay
Upon completion of the Acquisition of NettaGrowth International Inc., Khiron´s total production capacity is expected to increase to up to 220 tonnes Diversifies Khiron´s licence composition to include adult use and flower cultivation distribution capabilities Secures a scientific and investigation agreement with Institute Pasteur of Montevideo, a respected biotechnology researcher and developer in Uruguay Concurrent with closing, Mr. Michael Beck, experienced capital markets professional and entrepreneur, to join the board of Khiron, and Mr. Joseph Mimran, experienced brand builder and entre...
Apr 09, 2019 08:56 am ET
IIROC Trading Halt - KHRN
VANCOUVER, April 9, 2019 /CNW/ - The following issues have been halted by IIROC:
Apr 08, 2019 07:11 am ET
Khiron Life Sciences Hires Management Team to Lead Dixie Brands Joint Venture and Continue Market Expansion Strategy in Chile and Mexico
Seasoned capital markets leader and cannabis authority John Cooke is appointed VP of Corporate Development Luis Chavas to manage corporate development strategy and guide regulatory affairs for the Company in Mexico Rodrigo Azócar appointed Country Manager for Chile, to lead Company's market development and patient association strategy Rodrigo Durán appointed to lead previously announced Dixie Brands joint venture to bring Dixie's 100+ market-leading products to Latin America New hires bring Company employee count to 200+ across its four jurisdictions TORONTO, April 8, 2019 /CNW/ - Khiron Li
Apr 08, 2019 07:11 am ET
Khiron Life Sciences Hires Management Team to Lead Dixie Brands Joint Venture and Continue Market Expansion Strategy in Chile and Mexico
Seasoned capital markets leader and cannabis authority John Cooke is appointed VP of Corporate Development Luis Chavas to manage corporate development strategy and guide regulatory affairs for the Company in Mexico Rodrigo Azócar appointed Country Manager for Chile, to lead Company's market development and patient association strategy Rodrigo Durán appointed to lead previously announced Dixie Brands joint venture to bring Dixie's 100+ market-leading products to Latin America New hires bring Company employee count to 200+ across its four jurisdictions TORONTO, April 8, 2019 /PRNewswire/ - Kh...
Apr 04, 2019 12:05 am ET
Khiron Life Sciences Hosts Canadian Pavilion at Cannamexico World Summit 2019, Targeting over 2,000 Global Cannabusiness Leaders
One of the largest and most influential cannabis conferences in Latin America Two-day conference to attract over 2,000 attendees from more than ten countries First Canadian Pavilion welcomes prominent Canadian and global cannabis industry leaders Canadian Pavilion partners include MNP, Cardiol Therapeutics Inc., BMO and Dixie Brands. As previously announced, Dixie Brands and Khiron have established a joint venture to bring Dixie Brands' 100+ category-leading SKU's to the Latin American marketplace Summit co-hosted by Vicente Fox, 55th President of Mexico, former CEO of Coca-Cola Mexico and K
Apr 04, 2019 12:05 am ET
Khiron Life Sciences Hosts Canadian Pavilion at Cannamexico World Summit 2019, Targeting over 2,000 Global Cannabusiness Leaders
One of the largest and most influential cannabis conferences in Latin America Two-day conference to attract over 2,000 attendees from more than ten countries First Canadian Pavilion welcomes prominent Canadian and global cannabis industry leaders Canadian Pavilion partners include MNP, Cardiol Therapeutics Inc., BMO and Dixie Brands. As previously announced, Dixie Brands and Khiron have established a joint venture to bring Dixie Brands' 100+ category-leading SKU's to the Latin American marketplace Summit co-hosted by Vicente Fox, 55th President of Mexico, former CEO of Coca-Cola Mexico and K...
Apr 03, 2019 12:05 am ET
Khiron Expands Kuida® Retail Presence, Securing Partnerships With Fedco, Colombia's Top Specialist Beauty Retailer And Linio, Latin America's Largest Online E-Retailer
Retail distribution with Fedco, the first and most established specialized beauty retailer in Colombia, with 22 stores expanding reach to 50% of Colombia's territory Online distribution secured with Colombian e-retailer Linio, controlled by Grupo SACI Falabella, the largest retailer in Latin America with approximately US$15 billion in revenue in 2017 Increases Kuida® brand retail exposure to 78 store locations and approximately 600,000 monthly e-commerce visitors New agreements demonstrate continued first-mover advantage following successful initial Farmatodo product launch TORONTO, April 3
Apr 03, 2019 12:05 am ET
Khiron Expands Kuida® Retail Presence, Securing Partnerships With Fedco, Colombia's Top Specialist Beauty Retailer And Linio, Latin America's Largest Online E-Retailer
Retail distribution with Fedco, the first and most established specialized beauty retailer in Colombia, with 22 stores expanding reach to 50% of Colombia's territory Online distribution secured with Colombian e-retailer Linio, controlled by Grupo SACI Falabella, the largest retailer in Latin America with approximately US$15 billion in revenue in 2017 Increases Kuida® brand retail exposure to 78 store locations and approximately 600,000 monthly e-commerce visitors New agreements demonstrate continued first-mover advantage following successful initial Farmatodo product launch TORONTO, April 3...
Apr 01, 2019 07:00 am ET
Khiron Life Sciences President Chris Naprawa to Present at BMO 2019 Cannabis Conference
TORONTO, April 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will be presenting at the BMO 2019 Cannabis Conference, taking place April, 4th, 2019 in Toronto.
Mar 28, 2019 08:00 am ET
CBD is Heading South; Hemp/CBD Markets Spreading into Mexico and South America
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how, as CBD gains momentum in the US, companies are eyeing the next potential markets; mainly south of the border in Mexico and...
Mar 28, 2019 07:36 am ET
Khiron VP of Compliance Matt Murphy to Represent Company on U.S. National Cannabis Roundtable With John Boehner, Former Speaker of the U.S. House of Representatives
Matt Murphy, Khiron Vice President of Compliance, and former DEA Chief of Pharmaceutical Investigations recognized for long-time global advocacy and expertise on regulated cannabis markets around the world with appointment to represent Company on National Cannabis Roundtable Representation of Khiron in expanding on its advocacy for functioning global cannabis markets based on fulsome regulation product systems and controls John Boehner, former US Speaker of the House Representatives, will serve as Honorary Chairman of the National Cannabis Roundtable TORONTO, March 28, 2019 /CNW/ - Khiron
Mar 22, 2019 08:00 am ET
Vertically Integrated Cannabis Companies on Tour: A New Era of Confidence as Regulations Change
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how companies are expanding their footprint and vertical integrated operations. In parallel, management is on the road, spreading...
Mar 14, 2019 02:00 am ET
Dixie Brands and Khiron Life Sciences to bring more than 100 market-proven products to the Latin American cannabis market
Dixie Khiron JV Corp. formally established to bring Dixie Brands portfolio of cannabis-infused products to Latin America Dixie and Khiron are 50/50 JV co-owners JV introduces Khiron's Kuida® brand to the U.S. market, with special focus on the Hispanic population of almost 60 million JV has full access to Dixie's portfolio of more than 100 SKUs sold over the past 9 years in world's most mature cannabis markets Dixie-Khiron to enjoy first-mover advantage in Latin American market of 620 million people LatAm cannabis market estimated to reach $12 billion by 2028 (source: Prohibition Partners) D
Mar 13, 2019 07:00 am ET
Khiron Life Sciences Expands Skincare Leadership Team With The Appointment Of Dr. Edwin Bendek as Medical Director, Skincare
Appointment further strengthens commercial skincare business where Company was first to launch products into Colombia market in 2018 Skincare unit targets $10 Billion Latin America skincare market Dr. Bendek a recognized pioneer in CBD cosmeceutical product innovation Appointment expands expertise in general dermatology, cutaneous surgery, anti-aging dermatology and predictive genetics with appointment of Dr. Bendek TORONTO, March, 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leade
Mar 12, 2019 08:51 am ET
Khiron Life Sciences President Chris Naprawa To Present at 2019 LD Micro Virtual Conference
TORONTO, March 12, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will be presenting at the second annual LD Micro Virtual Conference on March 13th at 12:20pm EDT.
Mar 12, 2019 08:00 am ET
THC to CBD: More Cannabis Companies Expand Their CBD Capabilities
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing number of cannabis companies expanding their CBD capabilities, following the major market trends for 2019. Every...
Mar 08, 2019 08:00 am ET
CBD Products Coming to a Store near You; CBD Companies Expand Reach
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the flurry of new distribution and marketing deals within the CBD sector, opening up product availability to a growing consumer...
Mar 05, 2019 08:14 am ET
Khiron Introduces Kuida®, First Colombian CBD Cosmeceutical brand At Cosmoprof Worldwide Bologna, Targeting 200,000 Potential Global Retail Buyers
Kuida® introduced as first Colombian mass-market CBD Cosmeceutical brand at Cosmoprof Event attracts up to 200,000 global retail buyers (Source: BolognaFiere Group ) Khiron Skin Unit Director to speak on CBD-based cosmetics expert panel Global skincare market expected to reach US$131 Billion in 2019 TORONTO, March 5, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will participate in Cosmoprof Worldwide Bologna
Mar 04, 2019 08:30 am ET
MEDIA ADVISORY: Khiron Life Sciences and CentroFox Host Cannamexico World Summit Toronto Reception and Q&A With Former Mexican President Vicente Fox
TORONTO, March 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will host a Toronto reception on Thursday, March 7 to announce Cannamexico World Summit 2019, one of the largest and most influential cannabis conferences in Latin America. The Toronto reception will introduce the summit agenda, the first Canadian Pavilion and feature an exclusive on-stage Q&A with Mr. Vicente Fox, the 55th President of Mexico
Feb 28, 2019 09:22 am ET
Khiron Announces Closing of $28.84 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Feb 20, 2019 09:05 am ET
Three of the Best Ways to Invest in Colombia's Fast-Growing Medical Marijuana Market
HOUSTON, TX / ACCESSWIRE / February 20, 2019 / Colombia is on its way to becoming one of the largest global exporters of medical marijuana.
Feb 19, 2019 09:34 am ET
IIROC Trading Halt - KHRN
VANCOUVER, Feb. 19, 2019 /CNW/ - The following issues have been halted by IIROC:
Feb 19, 2019 09:29 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, Feb. 19, 2019 /CNW/ - Trading resumes in:
Feb 14, 2019 08:58 am ET
Top 3 Cannabis Stocks Higher on Colombian Growth Story
HOUSTON, TX / ACCESSWIRE / February 14, 2019 / Colombia is just beginning to transform itself into a multi-billion-dollar cannabis producer for the pharmaceutical industry. In time, growers estimate that the country could capture as much as a fifth of a global market that could be worth $40 billion a year, according to Reuters.
Feb 08, 2019 08:00 am ET
Branding Becomes Key as CBD is Expected to Overtake the Cannabis Market
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot reporting on the CBD market As it grows, branding becomes essential to companies hoping to stand out. According to Brightfield Group...
Feb 06, 2019 11:00 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, Feb. 6, 2019 /CNW/ - Trading resumes in:
Feb 06, 2019 10:39 am ET
Khiron Life Sciences announces upsize of previously announced bought deal equity financing to $25 million
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 06, 2019 08:26 am ET
IIROC Trading Halt - KHRN
VANCOUVER, Feb. 6, 2019 /CNW/ - The following issues have been halted by IIROC:
Feb 06, 2019 06:31 am ET
Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 04, 2019 07:35 am ET
Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
NEW YORK, Feb. 4, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series,  and KCSA Strategic Communications, announced that the presentations from the January 30th Cannabis Virtual Conference are now available for on-demand viewing at VirtualInvestorConferences.com. ...
Jan 31, 2019 07:27 am ET
Reminder: Dixie Brands and Khiron Life Sciences to Host Investor Call
DENVER and TORONTO, Jan. 31, 2019 /CNW/ - Dixie Brands Inc. ("Dixie") (CSE: DIXI.U), (Frankfurt: 0QV), one of the cannabis industry's leading consumer packaged goods companies, and Khiron Life Sciences Corp. ("Khiron") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated medical cannabis company focused on Latin America, cordially invite investors to join them for a conference call presentation to be held later today.
Jan 30, 2019 07:23 am ET
Transformative Joint Venture Between Dixie Brands and Khiron Life Sciences Brings a Portfolio of Highly Recognized Cannabis-Infused Products to Latin America and Khiron's Kuida® Cosmeceutical Brand to
Establishes Khiron as Latin America's CPG leader with the addition of over 100 product SKUs across 15 categories immediately available to commercialize into Latin American pharmacies and retail outlets Gives Khiron immediate access to Dixie's portfolio of proprietary formulations driven by years of product development and brand building in existing federally legal markets Accelerates Khiron's high margin product strategy in Latin America and positions Khiron as the cannabis CPG and Pharma focused leader in the region, combined with its scaled low-cost cultivation strategy Provides Dixie with
Jan 29, 2019 12:41 pm ET
/C O R R E C T I O N -- VirtualInvestorConferences.com/
In the news release, Khiron Life Sciences to Webcast Live at VirtualInvestorConferences.com on January 30th, issued 28-Jan-2019 by VirtualInvestorConferences.com over PR Newswire, we are advised by the company that the presentation time below the first paragraph was incorrect and should read "10am EST" rather than "9:30am EST" as originally issued inadvertently. The complete, corrected release follows:...
Jan 28, 2019 05:59 pm ET
Khiron Life Sciences to Webcast Live at VirtualInvestorConferences.com on January 30th
TORONTO, Jan. 28, 2019 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today that Khiron president Chris Naprawa will present live at VirtualInvestorConferences.com on January 30th, where he will discuss recent Company activity and the Latin American cannabis market....
Jan 25, 2019 08:23 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, Jan. 25, 2019 /CNW/ - Trading resumes in:
Jan 25, 2019 08:17 am ET
Khiron Life Sciences Signs Binding LOI to Acquire 100% of NettaGrowth, Securing the First Medical THC and CBD Cannabis Licence and Cultivation Capacity in Uruguay, and Entry to the Brazilian Market
Licenced for up to 120 tonnes of cannabis production per year Up to 170,000 plants Allows for the export of dry flower Further diversifies Khiron's production capability to three countries in Latin America Retail marketing legend, Joseph Mimran to join Khiron Colombia SAS Board Michael Beck, iconic capital markets veteran, and company builder to join Khiron Board of Directors TORONTO, Jan. 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Latin America
Jan 25, 2019 06:35 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present January 30
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com
Jan 25, 2019 06:35 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present January 30
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com...
Jan 24, 2019 03:03 pm ET
IIROC Trading Halt - KHRN
VANCOUVER, Jan. 24, 2019 /CNW/ - The following issues have been halted by IIROC:
Jan 21, 2019 06:09 am ET
Jan 18, 2019 10:22 am ET
Khiron Life Sciences Launches Latin American Medical Education Program With Events in Colombia and Mexico
Program launches with endorsement from one of Mexico's leading medical associations
Jan 17, 2019 12:39 pm ET
Khiron Life Sciences Announced as Co-Host of Cannamexico World Summit 2019
Andres Galofre, Khiron Co-founder and Vice-president of Business Development appointed to Cannamexico Board of Directors
Jan 11, 2019 06:49 am ET
Khiron Life Sciences to Present as Lead Sponsor in First CannaTech Panama Global Medical Cannabis Summit
Conference brings together global leaders in medical cannabis science, finance, agri-tech and policy
Dec 31, 2018 06:00 am ET
Khiron Life Sciences Added to Horizons Marijuana Life Sciences Index ETF
Addition marks milestone for Company as the LatAm integrated medical cannabis market leader
Dec 20, 2018 09:00 am ET
Uptick Newswire Hosts Khiron Life Sciences Corp.’s President to Discuss the Growing Latin American Cannabis Market and How They Have Positioned Themselves as a Leader
Uptick Newswire Stock Day Podcast features Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: 4KH), an integrated medical cannabis company with its core operations in Colombia. President of the company,...
Dec 13, 2018 08:30 am ET
Khiron Life Sciences Completes Acquisition of ILANS
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce that, further to press releases issued on...
Dec 11, 2018 06:00 am ET
Khiron Life Sciences Receives Endorsement from Prominent Colombian Medical Association for the Study of Pain
Endorsement furthers Khiron's patient-focused approach to medical cannabis research and product development
Dec 03, 2018 06:25 am ET
Khiron Life Sciences Enters Mexican Cannabis Market With The Launch of Its First Nutraceutical Product Line
TORONTO, Dec. 3, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today that its wholly-owned subsidiary, Kuida Life Mexico S.A., has received approval from Mexico's Federal Commission for the Protection against Sanitary Risk  (COFEPRIS) to import and commercialize three products of the Company's Nutraceutical Line. The commencement of sales in Mexico is subject to prior TSX Venture Exchange ("TSXV") approval.
Nov 29, 2018 06:15 pm ET
Khiron Life Sciences Reports Third Quarter Fiscal 2018 Financial Results
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today its financial results for the third quarter ended...
Nov 27, 2018 06:00 am ET
Khiron Life Sciences Enters Peruvian Cannabis Market With Approval For Commercialization Of Kuida® CBD Cosmeceutical Brand
Entry into Peru expands access to US $110 Billion Latin American beautycare market
Nov 19, 2018 06:00 am ET
Khiron Life Sciences Achieves Milestone With Additional Cultivation Quotas From The Colombian Technical Quotas Group
Quotas represent progress towards cultivating strains for commercial purposes in Q1 of 2019
Nov 15, 2018 11:51 am ET
Khiron Life Sciences Announces Completion of Warrant Acceleration
TORONTO, Nov. 15, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce that the Company has received  $14,007,000 from the exercise of warrants of which the expiry date was accelerated to November 14, 2018 (the "Warrants"), as previously announced on October 25, 2018. A total of 11,672,250 warrants were exercised, representing 96% of the Warrants, at a price of $1.20 per Warrant. With the exercise of the Warrants, the unaudited
Nov 15, 2018 11:51 am ET
Khiron Life Sciences Announces Completion of Warrant Acceleration
TORONTO, Nov. 15, 2018 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce that the Company has received  $14,007,000 from the exercise of warrants of which the expiry date was accelerated to November 14, 2018 (the "Warrants"), as previously announced on October 25, 2018. A total of 11,672,250 warrants were exercised, representing 96% of the Warrants, at a price of $1.20 per Warrant. With the exercise of the Warrants, the una...
Nov 08, 2018 06:00 am ET
Khiron Life Sciences Welcomes Cannabis Legislation Proposed by Incoming Government of Mexico
TORONTO, Nov. 8, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, welcomes the initiative presented today by the incoming Government of Mexico through its next secretary of the Interior, Dr. Olga Sánchez Cordero, for the Regulation and Control of Cannabis in Mexico.
Nov 06, 2018 06:00 am ET
Khiron Life Sciences Announces Mexican Retail Distribution for Kuida® CBD Cosmeceutical Brand
Agreement part of strategy targeting the US $7.3 Billion* skincare market in Mexico
Nov 05, 2018 11:04 am ET
Khiron Life Sciences Applauds Government of Mexico on Announcing Guidelines for the Production and Import of Medical Cannabis Products
Khiron positioned to reach Mexican population of over 120 million and market of 11.7 million potential patients for medical cannabis (source: IMS Quintiles 2017)
Oct 26, 2018 07:00 am ET
Khiron Secures Endorsement from the Leading Palliative Care Association in Colombia
Exclusive agreement represents significant initial milestone related to Khiron´s strategy of meeting the medical needs of 4 million palliative care patients in Latin America
Oct 25, 2018 07:23 am ET
Khiron Life Sciences Announces Acceleration of Expiry Date of Warrants
TORONTO, Oct. 25, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN, OTCQB: KHRNF, Frankfurt: A2JMZC), a Canadian integrated medical cannabis company with its core operations in Colombia, is pleased to announce that the Company has elected to exercise its right under the warrant indenture (the "Indenture") governing the common share purchase warrants of the Company (the "Warrants") issued on January 12, 2018. Pursuant to the terms of the Indenture, the Company may accelerate the expiry date of the Warrants when the closing price of the common shares of the Compa
Oct 24, 2018 07:00 am ET
Khiron Life Sciences Announces Launch of Khiron Clinics With the Signing of the Definitive Agreement to Acquire ILANS
Acquisition of ILANS, with 100,000 patients, a first step towards creating the leading clinic network in Latin America
Oct 02, 2018 07:00 am ET
Khiron Life Sciences Corp. Announces Colombian Retail Distribution Partners for Kuida® CBD Cosmeceutical Brand
Partnerships ensure first mover advantage and immediate revenue generation
Sep 28, 2018 07:00 am ET
Khiron Life Sciences Corp. Announces Formation of Wellness Business Unit and the Launch of Its First CBD Cosmeceutical Brand
First to market strategy establishes a cosmeceutical brand in the fast-growing Latin America skin care sector with innovative CBD-based consumer products
Sep 27, 2018 07:00 am ET
Sep 26, 2018 01:14 pm ET
Khiron Life Sciences Announces Incorporation into Horizons Emerging Marijuana Growers Index ETF
TORONTO, Sept. 26, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN, OTCQB: KHRNF, Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce its incorporation into the Horizons Emerging Marijuana Growers Index ETF (NEO: HMRJ) (the "ETF").  
Sep 26, 2018 07:30 am ET
Horizons ETFs Completes Rebalances of its Marijuana-focused ETFs
TORONTO, Sept. 26, 2018 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ:TSX") and the Horizons Emerging Marijuana Growers Index ETF ("HMJR:NEO").
Sep 26, 2018 07:00 am ET
Khiron Life Sciences Director and Former President of Mexico, Mr. Vicente Fox to Present Keynote Address at Global Cannabis Business Conference in Jamaica
Conference to offer insight on global medicinal, health, regulatory, business and investment landscape
Sep 12, 2018 10:57 am ET
Khiron Life Sciences Corp. to Present at Virtual Investor Conference
Live Webcast Scheduled for September 12, 2018, 2:00pm EDT, followed by Q&A
Sep 12, 2018 10:57 am ET
Khiron Life Sciences Corp. to Present at Virtual Investor Conference
Live Webcast Scheduled for September 12, 2018, 2:00pm EDT, followed by Q&A...
Sep 12, 2018 09:37 am ET
Khiron announces closing of $12.93 million prospectus financing including full exercise of over-allotment option
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Sep 06, 2018 08:35 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12
Cannabis company executives share vision, answer questions live at VirtualInvestorConferences.com
Sep 06, 2018 08:35 am ET
Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12
Cannabis company executives share vision, answer questions live at VirtualInvestorConferences.com...
Aug 23, 2018 09:42 am ET
IIROC Trading Resumption - KHRN
VANCOUVER, Aug. 23, 2018 /CNW/ - Trading resumes in:
Aug 23, 2018 07:34 am ET
Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Aug 21, 2018 01:21 pm ET
Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN, OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, reports that it has filed a preliminary short form prospectus with the securities...
Aug 21, 2018 01:18 pm ET
IIROC Trade Halt - Khiron Life Sciences Corp.
Vancouver, British Columbia--(Newsfile Corp. - August 21, 2018) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.
Aug 21, 2018 01:12 pm ET
IIROC Trading Halt - KHRN
VANCOUVER, Aug. 21, 2018 /CNW/ - The following issues have been halted by IIROC:
Aug 15, 2018 04:30 pm ET
Khiron lists on OTCQB Venture Market
TORONTO, Aug. 15, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQB: KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has successfully applied and been accepted for listing to the OTCQB Venture Market stock platform. The common shares of the Company will trade under the ticker symbol KHRNF.
Aug 13, 2018 09:47 am ET
Khiron CEO Alvaro Torres to Speak at Global Cannabis Business Conference in Toronto
International panel will discuss latest cannabis science and research, product innovation and organizational growth strategies
Aug 07, 2018 02:51 pm ET
IIROC Trading Resumption - KHRN
VANCOUVER, Aug. 7, 2018 /CNW/ - Trading resumes in:
Aug 07, 2018 02:34 pm ET
Khiron Signs Letter of Intent to Acquire Colombia's Leading Health Network
Acquisition to deliver network of 100,000 patients that meet Khiron's indicated targets 
Aug 07, 2018 08:28 am ET
IIROC Trading Halt - KHRN
VANCOUVER, Aug. 7, 2018 /CNW/ - The following issues have been halted by IIROC:
Aug 02, 2018 08:30 am ET
Khiron Expands Medical Cannabis Cultivation Capacity and Advances Towards Commercialization
Increased capacity to meet market demand and advance the Company's objective of addressing the medical needs of 1 million patients in Latin America
Jul 17, 2018 04:18 pm ET
IIROC Trading Resumption - KHRN
VANCOUVER, July 17, 2018 /CNW/ - Trading resumes in:
Jul 17, 2018 01:50 pm ET
Khiron Life Sciences, Medical Cannabis for Latin America, CEO Clip Video
Vancouver, British Columbia--(Newsfile Corp. - July 17, 2018) - Alvaro Torres, CEO of Khiron Life Sciences Corp., speaks on the company's plan to service the 640 million people in Latin America with medicinal cannabis.
Jul 17, 2018 10:56 am ET
Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
Appointment expands business and political network and furthers development of medical cannabis education and research across Latin America
Jul 16, 2018 11:23 am ET
IIROC Trading Halt - KHRN
VANCOUVER, July 16, 2018 /CNW/ - The following issues have been halted by IIROC:
Jul 05, 2018 12:38 pm ET
Khiron Life Sciences Expands CBD-Based Wellness Product Portfolio With Additional Authorizations from Colombian National Food and Drug Surveillance Institute (INVIMA)
TORONTO, July 5, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that further to its announcement of May 30, 2018, the Colombia National Food and Drug Surveillance Institute ("INVIMA") has granted Khiron authorization for the production, sale and export of four additional cannabidiol ("CBD") based products for skin and body care.
Jun 26, 2018 08:00 am ET
Khiron Expands Leadership Team with Appointment of Chris Naprawa as President
TORONTO, June 26, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today the appointment of Chris Naprawa as President, effective immediately. Mr. Naprawa, who will report to Alvaro Torres, CEO, will lead Khiron's capital markets activities, including outreach to existing and potential shareholders in Canada and internationally. This appointment is expected to increase the Company's visibility amongst institutional investors and provides greater depth of management
Jun 25, 2018 12:35 pm ET
Khiron Appoints Internationally Recognized Medical Cannabis Specialist Dr. Maria Fernanda Arboleda as Medical Director
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./
Jun 22, 2018 10:30 am ET
Grit Capital launches GritCAMP Immersive Investment Conference in Muskoka July 25-27th 2018
GRIT CAPITAL INC. (“Grit Capital” the “Company”) a capital markets advisory firm known for its aggressive “out of the box” thinking to capture mindshare announced today the launch of GritCAMP Immersive Investment Conference in Muskoka, ON July...
Jun 21, 2018 10:46 am ET
Khiron Life Sciences Corp. Applauds Election of Iván Duque as President of Colombia
President-Elect's platform promises significant economic measures to increase foreign investment and international trade
Jun 19, 2018 08:23 am ET
Khiron VP, Compliance Matt Murphy Appears on CBS Network's 60 Minutes to Discuss Law Enforcement and the Global Opioid Crisis
Former DEA Chief of Pharmaceutical Investigations leading Khiron's best-in-class procedures to self-regulate on diversion control
Jun 14, 2018 08:00 am ET
Khiron Forms Exclusive Strategic Alliance with ILANS, Expanding Distribution Network to Over 500,000 Patients
Demonstrates scalability and recurring revenue potential in the Colombian and Latin American markets
Jun 13, 2018 08:00 am ET
Khiron Achieves Key Milestone in Mission to Become First Medical Cannabis Company to Bring Products to Market in Colombia
Colombian Agricultural Institute ("ICA") authorization is a significant requirement to cultivate and distribute medical cannabis in Colombia. Khiron's receipt of the authorization confirms the Company as one of the leading medical cannabis companies in Latin America